CoQ10 vs Idebenone
Written by Aaron CuhaReviewed Sep 2026
The short answer
A supplement, and a lab made copy of it that became a medicine for one rare disease. The European Union allowed idebenone under special rules because the normal evidence bar was not met, and its trial missed its main goal.
- CoQ10 people
- 162
- CoQ10 nulls
- 1
- Idebenone people
- 732
- Idebenone nulls
- 2
Dose
No human dose established
Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose.
2 completed trials, 162 people given it
Dose
No human dose established
Amounts that were given in studies sit in Human evidence on this page. None of them is a personal dose.
5 completed trials, 732 people given it
First-hand reports are counted on each profile and never added together. This page sets two published records side by side. It does not pick a winner.
Column A
CoQ10Coenzyme Q10 (ubiquinone and ubiquinol)
One strong study in people with serious heart failure cut major heart problems from 26% to 15%. For statin muscle pain, the reason most people take it, it did not help.
Column B
IdebenoneIdebenone, short-chain synthetic benzoquinone analogue of coenzyme Q10
Approved in the European Union for one rare inherited eye disease that causes sudden vision loss. The approval came under special rules because the normal evidence bar was not met. The study behind it missed its main goal, and the studies in Alzheimer's disease and Friedreich ataxia found no benefit.
Side by side, on the facts we can check
| What we compare | CoQ10 | Idebenone |
|---|---|---|
| Category | Antioxidant | Antioxidant |
| FDA status | Sold as a dietary supplement in the United States. Not approved to prevent or treat any condition. Approved as a drug in some other countries for certain heart conditions. | Not FDA approved for any use. Approved in the European Union as Raxone since September 2015, under exceptional circumstances, a special route used when a disease is too rare to collect full data. It treats Leber hereditary optic neuropathy, an inherited disease that causes sudden vision loss. It is also sold in skin care and in brain-boosting supplements. Neither of those is an approved use. |
| Half-life | Roughly 33 hours after oral dosing. Absorption is poor and highly dependent on fat co-ingestion, which is why dosing with a meal containing fat is the standard instruction. | Short in plasma, a matter of hours, with extensive first-pass metabolism to conjugated metabolites. |
| Molecular weight | 863.3 Da. Ubiquinol is the reduced form, 865.4 Da, marketed as better absorbed; head-to-head clinical outcome data comparing the two do not exist. | 338.4 Da |
| How it works | Your cells make CoQ10 on their own. It sits inside the mitochondria, the parts of the cell that make energy, and helps pass energy along. In one of its forms, ubiquinol, it also works as an antioxidant and helps recycle vitamin E. Statins block an enzyme your body uses to make cholesterol. The same pathway also makes CoQ10. That shared pathway is why people thought CoQ10 would fix statin muscle pain. The idea makes sense, and the studies still found nothing. A good theory is not a result. | Idebenone is a small, lab-made cousin of CoQ10. It can take electrons from an enzyme called NQO1 and hand them straight to a later step in the cell's energy chain, skipping a broken first step called complex I. That makes sense for a disease caused by complex I faults, which is what LHON is. It is why the drug found its use there, not as a general antioxidant. But it needs NQO1 to work. In cells short of NQO1, idebenone has been reported to kill cells instead of protecting them. So it only helps in tissues with the right enzyme. |
| Studies in people | 3 | 5 |
| Evidence | Moderate: 2 completed trials, 162 people given it | Moderate: 5 completed trials, 732 people given it |
| Legal status, US | Sold as a supplement | Not approved; sold in cosmetics and supplements |
Frequently asked questions
What is the difference between CoQ10 and Idebenone?
CoQ10: One strong study in people with serious heart failure cut major heart problems from 26% to 15%. For statin muscle pain, the reason most people take it, it did not help. Idebenone: Approved in the European Union for one rare inherited eye disease that causes sudden vision loss. The approval came under special rules because the normal evidence bar was not met. The study behind it missed its main goal, and the studies in Alzheimer's disease and Friedreich ataxia found no benefit.
Which has stronger research evidence, CoQ10 or Idebenone?
Each compound gets a band worked out from facts we counted, with the math shown. CoQ10 is Moderate (2 completed trials, 162 people given it). Idebenone is Moderate (5 completed trials, 732 people given it). That counts how much has been done in people. It does not rate whether either one works, and neither one is called the winner.
Are CoQ10 and Idebenone FDA-approved?
CoQ10: Sold as a dietary supplement in the United States. Not approved to prevent or treat any condition. Approved as a drug in some other countries for certain heart conditions.. Idebenone: Not FDA approved for any use. Approved in the European Union as Raxone since September 2015, under exceptional circumstances, a special route used when a disease is too rare to collect full data. It treats Leber hereditary optic neuropathy, an inherited disease that causes sudden vision loss. It is also sold in skin care and in brain-boosting supplements. Neither of those is an approved use..
Reviewed Sep 2026. This page puts two published records side by side. It is for learning, and it is not medical advice. When this site shows a dose, it is the dose a trial or a clinic actually used, or what people say they did, with the source attached. None of it tells you what to take.